Search research articles
Contact Us
Filters
Showing results (271-280 of 337) with videos related to
Page
of 34
Sort By:
JAMA Network Open
|
May 28, 2025
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials
Leah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, et al.
The Lancet. Infectious Diseases
|
May 9, 2024
Genotypic analysis of RTS,S/AS01<sub>E</sub> malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial
Michal Juraska, Angela M Early, Li Li, et al.
JAMA Network Open
|
May 23, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials
Leigh H Fisher, Jia Jin Kee, Albert Liu, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection
James I Mullins, Wenjie Deng, Elena E Giorgi, et al.
NPJ Vaccines
|
April 18, 2026
Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine
Holly Janes, Youyi Fong, Ying Huang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 4, 2023
Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy
Michal Juraska, Angela M Early, Li Li, et al.
The Journal of Clinical Investigation
|
October 8, 2019
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk
Scott D Neidich, Youyi Fong, Shuying S Li, et al.
Science Translational Medicine
|
March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Infectious Diseases
|
January 12, 2018
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
Youyi Fong, Xiaoying Shen, Vicki C Ashley, et al.
The Journal of Clinical Investigation
|
February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 337) with videos related to
Sort By:
Page
of 34
JAMA Network Open
|
May 28, 2025
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials
Leah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, et al.
The Lancet. Infectious Diseases
|
May 9, 2024
Genotypic analysis of RTS,S/AS01<sub>E</sub> malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial
Michal Juraska, Angela M Early, Li Li, et al.
JAMA Network Open
|
May 23, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials
Leigh H Fisher, Jia Jin Kee, Albert Liu, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection
James I Mullins, Wenjie Deng, Elena E Giorgi, et al.
NPJ Vaccines
|
April 18, 2026
Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine
Holly Janes, Youyi Fong, Ying Huang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 4, 2023
Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy
Michal Juraska, Angela M Early, Li Li, et al.
The Journal of Clinical Investigation
|
October 8, 2019
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk
Scott D Neidich, Youyi Fong, Shuying S Li, et al.
Science Translational Medicine
|
March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Infectious Diseases
|
January 12, 2018
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
Youyi Fong, Xiaoying Shen, Vicki C Ashley, et al.
The Journal of Clinical Investigation
|
February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Page
of 34